A hallmark of patients with severe COVID-19 is lymphopenia [8], characterized by a dramatic decrease in CD4+ and CD8+ T cells [8], CD8+ mucosal-associated invariant T (MAIT), and γδ T cells [9]. Here, CD8A is linked to lymphopenia.